LMO2 induces T-cell leukemia with epigenetic deregulation of CD4.

In this study, we present a remarkable clonal cell line, 32080, derived from a CD2-Lmo2- transgenic T-cell leukemia with differentiation arrest at the transition from the intermediate single positive to double positive stages of T-cell development. We observed that 32080 cells had a striking variegated pattern in CD4 expression. There was cell-to-cell variability, with some cells expressing no CD4 and others expressing high CD4. The two populations were isogenic and yet differed in their rates of apoptosis and sensitivity to glucocorticoid. We sorted the 32080 line for CD4-positive or CD4-negative cells and observed them in culture. After 1 week, both sorted populations showed variegated CD4 expression, like the parental line, showing that the two populations could interconvert. We determined that cell replication was necessary to transit from CD4(+) to CD4(-) and CD4(-) to CD4(+). Lmo2 knockdown decreased CD4 expression, while inhibition of intracellular NOTCH1 or histone deacetylase activity induced CD4 expression. Enforced expression of RUNX1 repressed CD4 expression. We analyzed the CD4 locus by Histone 3 chromatin immunoprecipitation and found silencing marks in the CD4(-) cells and activating marks in the CD4(+) population. The 32080 cell line is a striking model of intermediate single positive to double positive T-cell plasticity and invokes a novel mechanism for LMO2's oncogenic functions.

[1]  J. Aster,et al.  Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL. , 2011, Blood.

[2]  Patrick Rodriguez,et al.  Novel binding partners of Ldb1 are required for haematopoietic development , 2006 .

[3]  E. Seto,et al.  A Mechanism of Repression by Acute Myeloid Leukemia-1, the Target of Multiple Chromosomal Translocations in Acute Leukemia* , 2000, The Journal of Biological Chemistry.

[4]  X. Chen,et al.  Lmo2 Induces Hematopoietic Stem Cell‐Like Features in T‐Cell Progenitor Cells Prior to Leukemia , 2013, Stem cells.

[5]  J. Downing,et al.  Murine Leukemias with Retroviral Insertions at Lmo2 Are Predictive of the Leukemias Induced in SCID-X1 Patients Following Retroviral Gene Therapy , 2009, PLoS genetics.

[6]  Christine J. Williams,et al.  Antagonistic interactions between Ikaros and the chromatin remodeler Mi-2beta determine silencer activity and Cd4 gene expression. , 2007, Immunity.

[7]  G. Nolan,et al.  The transcriptional landscape of αβ T cell differentiation , 2013, Nature Immunology.

[8]  T. Grigliatti.  Position-effect variegation--an assay for nonhistone chromosomal proteins and chromatin assembly and modifying factors. , 1991, Methods in cell biology.

[9]  Soumya Joseph,et al.  LIM-domain-only proteins in cancer , 2013, Nature Reviews Cancer.

[10]  Alfred L. Fisher,et al.  Groucho-dependent and -independent repression activities of Runt domain proteins , 1997, Molecular and cellular biology.

[11]  L. Zon,et al.  TIF1γ Controls Erythroid Cell Fate by Regulating Transcription Elongation , 2010, Cell.

[12]  M. Cooper,et al.  Reversible Disruption of Thymic Function by Steroid Treatment1 , 2002, The Journal of Immunology.

[13]  M. Ciofani,et al.  Epigenetic propagation of CD4 expression is established by the Cd4 proximal enhancer in helper T cells. , 2010, Genes & development.

[14]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[15]  D. Littman,et al.  The CD4/CD8 lineage choice: new insights into epigenetic regulation during T cell development. , 2004, Advances in immunology.

[16]  F. Sigaux,et al.  Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse , 2011 .

[17]  E. Laurenti,et al.  Dynamic Regulation of Notch 1 and Notch 2 Surface Expression during T Cell Development and Activation Revealed by Novel Monoclonal Antibodies1 , 2009, The Journal of Immunology.

[18]  N. Copeland,et al.  Gene Therapy Insertional Mutagenesis Insights , 2004, Science.

[19]  B. Peterlin,et al.  Runx1 Binds Positive Transcription Elongation Factor b and Represses Transcriptional Elongation by RNA Polymerase II: Possible Mechanism of CD4 Silencing , 2005, Molecular and Cellular Biology.

[20]  C. D. de Graaf,et al.  The Lmo2 Oncogene Initiates Leukemia in Mice by Inducing Thymocyte Self-Renewal , 2010, Science.

[21]  T. Rabbitts,et al.  T cell tumorigenesis in Lmo2 transgenic mice is independent of V-D-J recombinase activity , 2001, Oncogene.

[22]  Jeroen A. A. Demmers,et al.  A Novel Complex, RUNX1-MYEF2, Represses Hematopoietic Genes in Erythroid Cells , 2012, Molecular and Cellular Biology.

[23]  Richard A Young,et al.  Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. , 2012, Cancer cell.

[24]  F. Bushman,et al.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. , 2008, The Journal of clinical investigation.

[25]  Mimi Wan,et al.  Nucleoprotein structure of the CD4 locus: Implications for the mechanisms underlying CD4 regulation during T cell development , 2008, Proceedings of the National Academy of Sciences.

[26]  K. Johansen,et al.  Chromatin structure and the regulation of gene expression: the lessons of PEV in Drosophila. , 2008, Advances in genetics.

[27]  S. Orkin,et al.  Tie2Cre-mediated gene ablation defines the stem-cell leukemia gene (SCL/tal1)-dependent window during hematopoietic stem-cell development. , 2005, Blood.

[28]  B. Peterlin,et al.  Differential Chromatin Looping Regulates CD4 Expression in Immature Thymocytes , 2007, Molecular and Cellular Biology.

[29]  M. Fischer,et al.  The Transcription Factor Zbtb7b Promotes CD4 Expression by Antagonizing Runx-Mediated Activation of the CD4 Silencer1 , 2007, The Journal of Immunology.

[30]  T. Yankee,et al.  Immature single-positive CD8+ thymocytes represent the transition from Notch-dependent to Notch-independent T-cell development. , 2011, International immunology.

[31]  D. Littman,et al.  Differential Requirements for Runx Proteins in CD4 Repression and Epigenetic Silencing during T Lymphocyte Development , 2002, Cell.

[32]  Stuart H. Orkin,et al.  An early haematopoietic defect in mice lacking the transcription factor GATA-2 , 1994, Nature.

[33]  A. Dean,et al.  A requirement for Lim domain binding protein 1 in erythropoiesis , 2010, The Journal of experimental medicine.

[34]  T. Rabbitts,et al.  The LMO2 T-Cell Oncogene Is Activated via Chromosomal Translocations or Retroviral Insertion during Gene Therapy but Has No Mandatory Role in Normal T-Cell Development , 2003, Molecular and Cellular Biology.

[35]  D. Littman,et al.  The epigenetic landscape of lineage choice: lessons from the heritability of CD4 and CD8 expression. , 2012, Current topics in microbiology and immunology.

[36]  Ryan K. Dale,et al.  Ldb1-nucleated transcription complexes function as primary mediators of global erythroid gene activation. , 2013, Blood.

[37]  T. Hoang,et al.  SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-Tα chain expression , 2000, Nature Immunology.

[38]  S. Morrison,et al.  Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution , 2009, Cell.

[39]  D. Littman,et al.  Evidence for distinct CD4 silencer functions at different stages of thymocyte differentiation. , 2002, Molecular cell.

[40]  C. Sherr,et al.  Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies. , 2011, Blood.

[41]  I. Screpanti,et al.  Steroid sensitivity of thymocyte subpopulations during intrathymic differentiation. Effects of 17 beta-estradiol and dexamethasone on subsets expressing T cell antigen receptor or IL-2 receptor. , 1989, Journal of immunology.

[42]  S. Orkin,et al.  Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL , 1995, Nature.

[43]  T. Rabbitts,et al.  The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  E. Rothenberg,et al.  Localization of the Domains in Runx Transcription Factors Required for the Repression of CD4 in Thymocytes1 , 2004, The Journal of Immunology.

[45]  X. Chen,et al.  LIM Domain Only-2 (LMO2) Induces T-Cell Leukemia by Two Distinct Pathways , 2014, PloS one.

[46]  D. Littman,et al.  Transcription factor AP4 modulates reversible and epigenetic silencing of the Cd4 gene , 2011, Proceedings of the National Academy of Sciences.

[47]  M. Evans,et al.  The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development , 1994, Cell.

[48]  Bruce Aronow,et al.  Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy. , 2007, The Journal of clinical investigation.

[49]  Keji Zhao,et al.  Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes , 2002, Nature.

[50]  M. Bevan,et al.  Surface Expression of Notch1 on Thymocytes: Correlation with the Double-Negative to Double-Positive Transition 1 , 2003, The Journal of Immunology.

[51]  J. Seavitt,et al.  The chromatin remodeler Mi-2beta is required for CD4 expression and T cell development. , 2004, Immunity.

[52]  R. Ceredig,et al.  A positive look at double-negative thymocytes , 2002, Nature Reviews Immunology.

[53]  D. Littman,et al.  RUNX proteins in transcription factor networks that regulate T-cell lineage choice , 2009, Nature Reviews Immunology.

[54]  J. Dick,et al.  Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance. , 2010, Blood.

[55]  M. Cleary,et al.  RUNX1 associates with histone deacetylases and SUV39H1 to repress transcription , 2006, Oncogene.

[56]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.